twenty-six member institutions of the central oncology group entered 154 patients in this two-armed , phase iii study comparing the effects of adriamycin , bleomycin , and ccnu against a variety of squamous cell carcinomas .
C0005740
bleomycin
C0007137
squamous cell carcinomas